In recognition of Colon Cancer Awareness month, Cancer Connect hosted a webinar on March 16th. Join us as we take a closer look at how advancements in diagnostic testing are making it possible to detect recurrence earlier and assess treatment response better.
Using ctDNA to Optimize Colorectal Cancer Management
- What is a circulating tumor DNA test and how is it used to manage colorectal cancer?
- How a tumor informed approach may provide additional insight to inform treatment decisions
- Predicting relapse and identifying patients who may benefit from chemotherapy
The program was moderated by: John Strickler, M.D.
How Precision Medicine in Oncology Has Dramatically Changed the Way Cancer is Diagnosed and Treated
And What Patients Need to Know
Associate Professor of Medicine, Associate Director Clinical Research – GI Oncology, Co-Leader, Duke Cancer Institute Molecular Tumor Board, Duke University